Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study.

Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study.

Item

http://www.wikidata.org/entity/Q41449756

Q41449756

about

Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study.

Item

http://www.wikidata.org/entity/Q41449756

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Agoraphobia and Follicle-Stimu ...... Prospective Randomized Study.

@en

type

Item

label

Agoraphobia and Follicle-Stimu ...... Prospective Randomized Study.

@en

prefLabel

Agoraphobia and Follicle-Stimu ...... Prospective Randomized Study.

@en

P1476

Agoraphobia and Follicle-Stimu ...... Prospective Randomized Study.

@en

P2093

David Mischoulon

http://www.w3.org/2001/XMLSchema#string

Hawoo Yi

http://www.w3.org/2001/XMLSchema#string

Hong Jin Jeon

http://www.w3.org/2001/XMLSchema#string

Jung-Yoon Heo

http://www.w3.org/2001/XMLSchema#string

Kiwon Kim

http://www.w3.org/2001/XMLSchema#string

Maurizio Fava

http://www.w3.org/2001/XMLSchema#string

Sechang Yoon

http://www.w3.org/2001/XMLSchema#string

P2860

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women

An Inventory for Measuring Depression

Reduction of cancer-specific thought intrusions and anxiety symptoms with a stress management intervention among women undergoing treatment for breast cancer

Breast cancer. Clinical practice guidelines in oncology

The assessment of anxiety states by rating

Development of a rating scale for primary depressive illness

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.

P304

491-498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4306/PI.2017.14.4.491

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jeong Eon Lee

P577

2017-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28845177

http://www.w3.org/2001/XMLSchema#string

P932

5561408

http://www.w3.org/2001/XMLSchema#string

Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study.

about

Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932